|
Volumn 34, Issue 7, 2002, Pages 2520-2522
|
Sirolimus and FTY720: New approaches to transplant immunosuppression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCINEURIN INHIBITOR;
CHEMOKINE RECEPTOR CCR7;
CYCLOSPORIN A;
EVEROLIMUS;
FINGOLIMOD;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
STEROID;
THERMOZYMOCIDIN;
DRUG DERIVATIVE;
IMMUNOSUPPRESSIVE AGENT;
PROPANEDIOL DERIVATIVE;
SPHINGOSINE;
ACUTE GRAFT REJECTION;
BONE MARROW SUPPRESSION;
BONE PAIN;
BRADYCARDIA;
CLINICAL TRIAL;
COMORBIDITY;
CONFERENCE PAPER;
DIARRHEA;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TREATMENT OUTCOME;
ARTICLE;
HISTOCOMPATIBILITY;
METHODOLOGY;
MULTICENTER STUDY;
CLINICAL TRIALS;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
MULTICENTER STUDIES;
PROPYLENE GLYCOLS;
SIROLIMUS;
SPHINGOSINE;
TRANSPLANTATION IMMUNOLOGY;
|
EID: 0036847239
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03472-3 Document Type: Conference Paper |
Times cited : (5)
|
References (7)
|